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1. Introduction
1.1. Motivation
Congestive heart failure (CHF) is a chronic disease affecting an estimated 5.7 million people in the United States 
and costing the US health care system over $30 billion (Heidenreich et al 2013, Benjamin et al 2018). Symptoms 
of CHF include fluid retention in the lungs, legs, and abdomen, shortness of breath, reduced exercise tolerance, 
and fatigue. While CHF-related mortality has reduced over the years, it has been accompanied by an increase in 
hospitalizations and readmissions (Roger 2013).
CHF management involves preserving heart function and minimizing fluid overload (Adamson 2009). Fluid 
management is particularly important because more than 90% of patients hospitalized for worsening CHF pre-
sent with signs and/or symptoms of fluid overload (Adams et al 2005). The standard of care involves follow up 
visits on a regular (e.g. monthly) basis, where the physician will measure the patient’s weight and look for clinical 
signs of fluid overload through physical examination and auscultation. Patients with CHF are encouraged to 
weigh themselves daily, monitor their blood pressure if they have hypertension, and maintain good medication 
and diet adherence.
M Delano and C Sodini
Evaluating calf bioimpedance measurements for fluid overload management in a controlled environment
Printed in the UK
125009
PMEAE3














Evaluating calf bioimpedance measurements for fluid overload 
management in a controlled environment
Maggie Delano1  and Charles Sodini2
1 Swarthmore College, Swarthmore, PA 19081, United States of America
2 Massachusetts Institute of Technology, Cambridge, MA 02139, United States of America
E-mail: mdelano1@swarthmore.edu
Keywords: bioimpedance, hemodialysis, congestive heart failure, fluid overload
Abstract
Objective: To evaluate the relationship between calf bioimpedance measurements and fluid removal 
in a controlled environment (hemodialysis) as a first step toward using these measurements for 
remote congestive heart failure (CHF) monitoring. Approach: Calf bioimpedance measurements 
were recorded in 17 patients undergoing hemodialysis (9/17 (53%) CHF, 5/17 (30%) female). 
Measurements were performed before and after hemodialysis. Additional parameters related to 
hemodialysis and patient fluid status such as estimated dry weight were also recorded. Main results: 
Calf bioimpedance changes depended on calf fluid status as assessed by calf normalized resistivity 
(CNR). Patients with lower calf fluid overload (as assessed by CNR greater than 0.1017 Ωm3 kg−1) 
had larger decreases in calf fluid than patients with higher calf fluid overload. High CNR patients 
had fluid changes within the calf that depended on the ultrafiltration rate, with patients with lower 
ultrafiltration rates experiencing fluid shifts from extracellular to intracellular fluid. Additionally, 
there were correlations between changes in calf extra-, intra- and total- water and the ultrafiltration 
volume removed for high CNR patients (R2 = 0.44, 0.42, 0.56, respectively, all p-values < 0.05). 
Significance: These results suggest that while the relationship between calf fluid status and total 
fluid status is complex, changes in calf volumes comparable to those expected in an ambulatory 
setting are measurable and relate to changes in total volume. This suggests that calf bioimpedance 
measurements for CHF remote monitoring warrant future investigation, as remote fluid status 
management could reduce fluid overload related hospitalizations in CHF patients.
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1.2. Remote fluid status monitoring
Weight monitoring has low levels of patient compliance and low sensitivity in predicting CHF decompensation 
(Abraham et al 2011b). There has been significant research interest in alternative remote/at home monitoring 
technologies, including implantable pressure monitors (Zile et al 2008, Adamson 2009, Abraham et al 2011a) 
and bioimpedance measurements (Yu et al 2005, Beckmann et al 2009, Weyer et al 2014, Shochat et al 2016). 
Pressure monitors have the advantage of measuring heart filling pressures directly or indirectly, which are the first 
measurable physiological markers to change during heart failure decompensation (Adamson 2009). However, a 
major limitation of pressure monitoring systems is the need for a costly and invasive implantation procedure.
Bioimpedance measurements can be performed invasively or non-invasively to estimate fluid status based on 
the electrical properties of the measured tissue (Grimnes and Martinsen 2015, Mulasi et al 2015). Most research 
has focused on trans- and intra-thoracic measurements in a clinic or at home setting (Schlebusch et al 2010, 
Conraads et al 2011, Anand et al 2012, Shochat et al 2016). However, the main invasive bioimpedance system 
(Medtronic Optivol) has a high false positive rate (Conraads et al 2011, Yang et al 2013) and does not appear to 
improve clinical outcomes (Veldhuisen et al 2011). Most subsequent research has focused on non-invasive bio-
impedance measurements in the clinic (Shochat et al 2015, 2016) or using wearable patches (Anand et al 2012, 
Ramos et al 2009). A limitation of chest-based monitoring systems is the need for sticky adhesives or tight bands/
shirts to ensure a reliable signal, which reduces their potential for long term use.
Although the lungs become congested before the periphery (Zile et al 2008), we hypothesize that bioimped-
ance measurements performed at the calf will reduce readmission rates as we expect them to be able to predict 
decompensation earlier and have improved patient compliance compared with weight scale based methods. 
Such a system could be embedded in compression socks that many CHF patients already wear. A challenge with 
using calf based measurements will be making a clinical assessment of overall volume status based on calf bioim-
pedance data.
Calf bioimpedance measurements have been used by other researchers to determine patient dry weight dur-
ing hemodialysis (Zhu et al 2008a, 2011, Montgomery et al 2013). Monitoring calf bioimpedance during hemo-
dialysis improves estimation of patient dry weight over the standard of care as the calf appears to be the last place 
to ‘dry out’ at the end of hemodialysis (Zhu et al 2008a). However, the relationship between changes in calf water 
and fluid removal are not well understood in hemodialysis or in an ambulatory setting.
This study is a preliminary evaluation of calf bioimpedance as a method for remote monitoring of CHF 
patients. The goals of this study were to (1) compare changes of calf fluid volumes (as assessed by bioimpedance) 
with removed fluid in a controlled environment (hemodialysis) and (2) compare bioimpedance-based assess-
ments of calf fluid status with other methods. We hypothesize that factors such as calf fluid overload, ultrafiltra-
tion rate and volume, and dialysate concentrations will influence changes in calf fluid status.
2. Methods
2.1. Informed consent
All patients gave informed consent to participate in the study and received hemodialysis in the inpatient unit 
at Massachusetts General Hospital in Boston, Massachusetts. All experimental procedures presented here were 
approved by the Institutional Review Board (Protocol #: 2015P001881). Inclusion criteria for this study were the 
following: age > 18 years, inpatients undergoing hemodialysis. Exclusion criteria were the following: pregnant 
women, inability to consent, amputations, metal in leg, active device in body (pacemaker, etc), inability to 
place electrodes on calf (e.g. calcification, ulcers). The study was not limited to CHF patients to improve rate of 
recruitment, which was limited based on bay availability in the hemodialysis unit.
2.2. Study design
Calf bioimpedance measurements were performed in a sweep of 256 logarithmically spaced frequencies from 
4 kHz to 1 MHz four times each immediately before and after hemodialysis treatment using a commercial 
bioimpedance device (ImpediMed SFB7, ImpediMed Inc., Carlsbad, CA) and 3M 2670 Ag/AgCl electrodes 
(Maplewood, MN). Four electrodes were placed longitudinally along the lateral side of the calf (see figure 1) and 
remained on the side of the calf for the study session, the duration of which was about 4 h, but depended on the 
individual patient. The researcher measured the distance between the middle of the patella (knee) and lateral 
malleolus (ankle) and placed the voltage electrodes 5 cm on either side of the midpoint of this distance. Current 
electrodes were placed 5 cm outside each voltage electrode. The patient was allowed to choose which leg the 
electrodes were placed on so long as the electrodes could be placed without possible interference from ulcers or 
other skin issues. Measurements were performed while the patient was in ‘semi-supine’ position (legs horizontal 
at the same level as their buttocks with torso slightly elevated by a hospital bed and resting on pillows). The 
patients maintained this position for the duration of the hemodialysis session. Hemodialysis parameters such 
as ultrafiltration rate (UFR), ultrafiltration volume (UFV), and dialysate concentrations were determined per 
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standard of care and not altered by the researchers. All ins and outs (saline flushes, food intake) were recorded. 
The volume of all saline flushes was subtracted from the removed ultrafiltration volume to determine the net 
ultrafiltration volume removed (Goossens 2015, Safadi et al 2017). Food intake was assumed to not impact calf 
compartment volumes.
2.3. Bioimpedance spectroscopy measurements
The magnitude of each bioimpedance measurement from 4 kHz to 200 kHz was fit to the Cole model (Cole 
1940) using MATLAB’s lsqcurvefit algorithm. The initial conditions for each fit went through 50 iterations using 
MATLAB’s MultiStart algorithm. The bioimpedance magnitude and cut-off frequency of 200 kHz were used to 
minimize the impact of high-frequency artifacts due to electrode mismatch that can occur when using the SFB7 
for segmental bioimpedance measurements (Bogónez-Franco et al 2009). The Cole model is a four-parameter 
model where the measured bioimpedance Z  can be represented by
Z = R∞ +
R0 − R∞
1 + ( jωτ)α (1)
where R0 is the resistance at frequencies  1/τ , R∞ is the resistance at frequencies  1/τ , τ  is the time constant 
associated with the characteristic frequency of the tissue, and α affects the frequency ‘width’ of the bioimpedance 
transition from R0 to R∞.
The Cole model can also be represented by a three element circuit model with two resistors and a constant 
phase element (see figure 2) (Grimnes and Martinsen 2015). At frequencies  1/τ , the constant phase element is 
an open circuit and current flows only through the conductive medium outside the cells known as extra-cellular 
water (ECW), represented as the resistor Re. At frequencies  1/τ , the constant phase element is shorted and 
current flows through both the extra- and intra-cellular water (Re (ECW) and Ri (ICW)). The total measured 
resistance at high frequencies is the parallel combination of Re and Ri, Re||Ri = R∞ and represents the total water 
of the measured segment (TW).
Each of the four bioimpedance measurements performed before and after the hemodialysis session were fit 
individually to obtain Cole parameters for each sweep. The mean and standard deviation values of these param-
eters were then used for subsequent analysis (see section 2.6).
2.4. Estimating calf volumes
Bioimpedance measurements and calf circumference measurements were used to calculate the volumes of the 
calf extra- and intracellular water. In this paper, calf extracellular water is abbreviated as cECW, calf intracellular 
water is abbreviated as cICW, and total calf water is abbreviated as cTW.
2.4.1. Estimating cECW
If one assumes that the calf is a homogeneous cylinder and that the cECW is the only conducting tissue at low 





where ρ  is the resistivity of the cylinder, L  is the length of the segment (in this case the inter-electrode distance or 
10 cm for all patients), and A is the cross sectional area (in this case the average of the circumference at the two 
voltage electrodes divided by 4π). By multiplying the right half of the equation by L/L, this equation can relate 







Figure 1. Electrode placement for bioimpedance measurements. Placement was chosen to be the same as Zhu et al (2008a). Current 
is driven through the I+ and I  −  electrodes, and the resulting voltage is sensed by the V+ and V  −  electrodes.
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where Volcalf = L ∗ A. Calculating the resistivity of the cylinder will allow the measured resistance to be related 
specifically to the cECW volume.




(1 − c)3/2 (6)
where ρECW  is the resistivity of the conductive fluid and c is a dimensionless volume fraction of the nonconducting 
spheres (Hanai 1960). A typical value for ρECW  is 40.5 Ω cm (Jaffrin and Morel 2008) and it is assumed that ρECW  
stays constant for the duration of the hemodialysis session. If one assumes only the cECW is conducting at low 
frequencies, c becomes
c = 1 − VolcECW
Volcalf
 (7)
where VolcECW  is the volume of the cECW in the cylinder. Plugging in equation (7) to equation (6), the resistivity 
















2.4.2. Estimating cTW and cICW











Figure 2. Three element circuit model representing bioimpedance measurements of tissue. Re  =  extracellular resistance, 
Ri  =  intracellular resistance, Cm  =  membrane capacitance, CPE  =  constant phase element.
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where ρ∞ has been shown by Matthie et al to be (Matthie 2005)






where ρICW = 4.5ρECW . The value of 4.5ρECW  was selected because results from different studies range between 
3–6 times ρECW  (Jaffrin and Morel 2008).
cICW is calculated from the difference between cTW and cECW:
VolcICW = VolcTW − VolcECW . (14)
It is also assumed that ρICW does not change over the course of the hemodialysis session. A change of ρICW  
from 4.5ρECW  to 3ρECW  or 6ρECW  would change VolcTW  by −10% and 10%, respectively and change VolcICW  by 
−25% and 25%, respectively.
2.5. Evaluation of fluid status
Patient fluid status was evaluated through a combination of whole-body and calf based measurements and 
assessments including an estimation of whole body fluid overload using estimated dry weight (EDW) as a 
percentage of total weight, the ultrafiltration volume (UFV) as a percentage of total weight, pedal edema scores, 
calf normalized resistivity, and the calf ECW/TW ratio. Serum sodium (as measured at the start of hemodialysis) 
was also recorded.
Whole body fluid overload was calculated as the difference between the patient’s weight at the start of the 
dialysis session and a clinician’s assessment of a patient’s estimated dry weight (EDW) as obtained from patient 
medical records. This was expressed as a percentage of the patient’s weight before hemodialysis.
The UFV as a percentage of total weight was calculated using net UFV (fluid out minus fluid in) and the 
patient’s weight before the hemodialysis session.
Pedal edema was scored on a scale of 0–3 by clinicians (also as obtained from patient medical records), where 
0  =  no visible edema, 1  =  trace edema, 2  =  significant edema, and 3  =  pitting edema.
Calf normalized resistivity (CNR) is a metric of calf hydration introduced by Zhu et al (2003, 2008a), Zhu 


















where R0 is the resistance at low frequencies (equivalent to the extracellular resistance Re), circ is the average 
of the calf circumference measured at each voltage electrode, L  is the inter-electrode distance between the two 
voltage electrodes, W  is the patient’s weight, and H is the patient’s height.
The calf ECW/TW ratio was calculated by dividing the estimated calf ECW (cECW) by the estimated calf 
total water (cTW).
2.6. Determining the standard deviation in calf volume measurements
There are multiple sources of variance in the calf volume measurements cECW, cICW, and cTW and CNR, 
including variability in the measured bioimpedance parameters R0 and R∞ and the calf circumference circ. In 
order to determine the overall standard deviation of the volume estimations, the standard deviations for each 
variable were combined as described in the appendix.
2.7. Statistical methods
Unpaired t-tests using Satterthwaite’s approximation for unequal variances were used to compare CHF and 
non-CHF patients. Paired t-tests were used to compare changes over the course of the hemodialysis session 
within a given group, such as CHF patients only or for all patients. Linear regressions were used to determine 
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the correlation between different parameters and the statistical significance of those parameters. The level of 
statistical significance for all tests was chosen to be p < 0.05.
3. Results
3.1. Patient demographics
Demographic and clinical information for patients recruited for the study (N = 17; five female; four Black, 
one Asian) is presented in table 1. All patients were on chronic hemodialysis treatment, with the exception of 
patient nine, who had acute kidney injury. All patients participated in the study for one session. Nine patients 
(53%) had CHF and nine patients had diabetes (53%). Four patients had both CHF and diabetes (24%). Patients 
were aged 63.5 ± 9.96 years and their average height was 174.0 ± 10.46 cm. Patient estimated dry weights were 
84.0 ± 21.51 kg and they had 2.0 ± 1.1 l of fluid removed over the course of their respective hemodialysis 
sessions. There were no statistically significant differences between CHF and non-CHF patients with respect 
to age, height, EDW or net UFV removed (p-values for unpaired t-test using Satterthwaite’s approximation for 
unequal variances of 0.23, 0.76, 0.78, and 0.98, respectively).
3.2. Calf volume changes
There were statistically significant changes in cECW in ml at the cohort level, and statistically significant changes 
in cECW in ml, cTW in ml and weight for CHF patients (see table 2). Changes in calf volumes were heterogeneous 
(see figure 3). Changes in cECW ranged from −30 ml up to 20 ml. 11/17 (65%) of patients had decreases in cECW, 
5/17 (29%) patients had no statistically significant change in cECW and one patient (6%) had a statistically 
significant increase in cECW. Changes in cICW ranged from −75 ml to 30 ml. 8/17 patients (47%) had a decrease 
in cICW, 7/17 (41%) patients had an increase in cICW, and 2/17 patients (12%) had no statistically significant 
change in cICW. Changes in cTW ranged from −75 ml to 20 ml. 9/17 (53%) of patients had a decrease in cTW, 
5/17 (30%) of patients had an increase in cTW and 3/17 (18%) of patients had no statistically significant change 
in cTW.
There were statistically significant correlations between changes in cTW (ml and %) and UFV as a percentage 
of initial weight for all patients (R2 = 0.23 and 0.27, respectively, both p-values < 0.05, full table of correlations 
can be found in table 3, see also figure 4). There was also a statistically significant, correlation between cTW (%) 
and UFR normalized by weight (R2 = 0.23, p < 0.05).
When considering only those patients with CNR > 0.1017 Ωm3 kg−13, there were statistically significant cor-
relations between each of the calf volume changes and UFR and UFV (except cICW changes for UFV).
When considering only those patients with CHF, there were statistically significant correlations between cTW 
(ml and %) and UFV and UFR (R2 = 0.50, 0.46, 0.55, 0.52, all ps < 0.05). There was also a statistically significant 
correlation between changes in cECW (ml) and UFR normalized by weight (R2 = 0.46, p < 0.05).
There were no statistically significant correlations between the sodium gradient (dialysate sodium–serum 
sodium) and any volume change, and the only statistically significant relationship between Initial CNR and vol-
ume changes was for cICW (%) for only CHF patients (R2 = 0.48, p < 0.05). There were also no statistically 
significant correlations between the study session duration and any calf volume changes.
3.3. Comparison of calf normalized resistivity to other metrics of fluid status
There were significant correlations between Initial CNR and Initial cECW/cTW (R2 = 0.63, p < 0.001, see 
figure 5), and Initial CNR and pedal edema score (R2 = 0.56, p < 0.001, see figure 6). These correlations were 
approximately equivalent when considering only CHF patients (R2 = 0.64, p < 0.01 and R2 = 0.57, p < 0.05, 
respectively). There was no statistically significant correlation between Initial CNR and clinically determined 
fluid overload.
4. Discussion
We found heterogeneity in the changes in calf volumes over the course of the hemodialysis session. Heterogeneity 
was particularly pronounced for patients with lower CNR (i.e. higher calf fluid overload).
4.1. Changes in cECW
Previous research has suggested that the calf is the last place to ‘dry out’ over the course of hemodialysis (Zhu et al 
2008b). This means that depending on how close a patient is to their estimated dry weight, the ratio between fluid 
in the measured portion of the calf compared with fluid elsewhere will change. Patients very close to dry weight 
3 The value of 0.1017 Ωm3 kg−1 was selected because it is a threshold at which the largest difference between two patient CNRs 
occurs.
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would be expected to have most of their excess fluid located in the calf. If we consider the relationship between 
changes in cECW and CNR (see figure 7), we find that the largest decreases in cECW occur at higher CNR, but 
not the highest measured CNR of all patients. We hypothesize that these patients have the largest changes in 
cECW because (1) most of their excess fluid is located in the calf and (2) they have lower fluid overload, so there is 
less refill of cECW from cICW (Isogai et al 1983). Patients with the highest measured CNR may already have been 
very close to their dry weight.
Patients with lower CNR show more variance. Of the patients with CNR below 0.1017 Ωm3 kg−1, 4/7 (57%) 
had no statistically significant change in cECW, 2/7 (29%) patients had decreases in cECW and 1/7 patients 
(14%) had an increase in cECW (the only patient in the study to have an increase).
Previous research has raised concerns about the impact of posture on changes during hemodialysis 
 (Montalibet et al 2016). When an individual moves from a sitting or standing position to a supine position, 
extracellular fluid shifts from the legs to the torso (Medrano et al 2010). These shifts can last for several hours in 
healthy volunteers. Because extracellular fluid (presumably) also leaves the calf during ultrafiltration (Zhu et al 
2008b), when a patient undergoing hemodialysis is supine after standing or sitting, changes in calf extracellular 
Table 1. Demographics of patients participating in the research study. EDW  =  estimated dry weight, UFV  =  net ultrafiltration volume 
removed, ESRD  =  end stage renal disease, CHF  =  congestive heart failure, DM  =  diabetes mellitus, AKI  =  acute kidney injury, —  =  data 
not available. There were no statistically significant differences between CHF and non-CHF patients with respect to age, height, EDW or 
UFV (p-values for unpaired t-test using Satterthwaite’s approximation for unequal variances of 0.39, 0.52, 0.87, and 0.98, respectively).
Patient Sex Age (yrs) Race Height (cm) EDW (kg) UFV (ml) Diagnosis
CHF
1 F 71 White 163 110.0 3.3 ESRD, CHF, DM
2 M 62 White 178 93.5 1.2 ESRD, CHF
3 M 62 White 178 82.5 2.8 ESRD, CHF
4 F 58 Black 163 70.0 2.5 ESRD, CHF, DM
6 M 67 White 175 60.5 1.0 ESRD, CHF
8 M 51 Black 173 80.5 3.4 ESRD, CHF
11 F 88 White 180 — 0.7 ESRD, CHF
13 M 65 White 178 — 1.0 ESRD, CHF, DM
15 M 66 White 163 98.0 2.4 ESRD, CHF, DM
Mean ± SD 65.6 ± 10.19 172.3 ± 7.28 85.0 ± 16.92 2.0 ± 1.07
Non-CHF
5 M 66 White 185 102.0 3.3 ESRD, DM
7 M 56 White 188 117.0 3.2 ESRD, DM
9 M 43 White 188 91.0 0.0 AKI
10 M 74 Black 188 50.0 2.0 ESRD
12 M 59 White 155 101.5 2.7 ESRD, DM
14 M 56 Black 168 69.5 1.5 ESRD, DM
16 F 70 White 175 50.0 2.5 ESRD
17 F 66 Asian 160 — 1.1 ESRD, DM
Mean ± SD 61.2 ± 9.84 175.9 ± 13.50 83.0 ± 26.72 2.0 ± 1.13
Total
Mean ± SD 63.5 ± 9.96 174.0 ± 10.46 84.0 ± 21.51 2.0 ± 1.06
Table 2. Selected measured parameters at the beginning (Initial) and end (Final) of the hemodialysis session. All listed p-values are for 
paired t-tests. ns  =  not significant (p > 0.05), *  =  p < 0.05. There were no statistically significant differences between CHF and non-CHF 
patients for any parameter at the start (Initial) or end (Final) of the hemodialysis session, nor were there statistically significant differences 
in the changes in these parameters (unpaired t-tests using Satterthwaite’s approximation).
All patients Non-CHF CHF
Initial Final p Initial Final p Initial Final p
cECW (ml) 230.6 ± 92.23 221.5 ± 97.42 * 245.5 ± 92.51 238.0 ± 97.88 ns 225.4 ± 98.34 215.2 ± 103.79 *
cICW (ml) 205.4 ± 66.13 200.0 ± 70.28 ns 202.9 ± 58.33 208.3 ± 65.89 ns 203.3 ± 78.22 185.5 ± 76.69 ns
cTW (ml) 436.0 ± 94.74 421.5 ± 100.93 ns 448.4 ± 82.00 446.3 ± 103.57 ns 428.7 ± 113.28 400.7 ± 105.55 *
cECW/cTW 0.5 ± 0.13 0.5 ± 0.14 ns 0.5 ± 0.13 0.5 ± 0.13 ns 0.5 ± 0.13 0.5 ± 0.15 ns
CNR  
(Ωm3 kg−1)
0.117 ± 0.04 0.110 ± 0.06 ns 0.111 ± 0.03 0.120 ± 0.04 ns 0.116 ± 0.04 0.094 ± 0.07 ns
Weight (kg) 82.3 ± 19.89 81.1 ± 20.06 ns 82.9 ± 23.95 82.2 ± 24.35 ns 81.5 ± 13.83 79.8 ± 13.46 *











Table 3. Correlations between changes in calf volumes and selected measured parameters. Listed values include an R2 value with p-value in parentheses. ns  =  not significant (p > 0.05), *  =  p < 0.05. ∆Na+  =  Dialysate sodium–serum 
sodium before hemodialysis. The threshold for High CNR was 0.1017 Ωm3 kg−1.
Initial CNR (Ωm3 kg−1) UFV (%) UFR (ml/h/kg) ∆Na + (mEq)
All High CNR CHF only All High CNR CHF only All High CNR CHF only All High CNR CHF only
∆ cECW (ml) 0.12 (ns) 0.34 (ns) 0.30 (ns) 0.09 (ns) 0.49 (*) 0.33 (ns) 0.08 (ns) 0.50 (*) 0.46 (*) 0.05 (ns) 0.00 (ns) 0.00 (ns)
∆ cECW (%) 0.21 (ns) 0.29 (ns) 0.36 (ns) 0.17 (ns) 0.46 (*) 0.30 (ns) 0.15 (ns) 0.44 (*) 0.40 (ns) 0.01 (ns) 0.00 (ns) 0.00 (ns)
∆ cICW (ml) 0.02 (ns) 0.09 (ns) 0.24 (ns) 0.18 (ns) 0.37 (ns) 0.29 (ns) 0.14 (ns) 0.41 (*) 0.29 (ns) 0.02 (ns) 0.11 (ns) 0.05 (ns)
∆ cICW (%) 0.02 (ns) 0.08 (ns) 0.48 (*) 0.09 (ns) 0.36 (ns) 0.07 (ns) 0.07 (ns) 0.42 (*) 0.08 (ns) 0.00 (ns) 0.11 (ns) 0.02 (ns)
∆ cTW (ml) 0.00 (ns) 0.18 (ns) 0.07 (ns) 0.23 (*) 0.52 (*) 0.50 (*) 0.19 (ns) 0.56 (*) 0.55 (*) 0.00 (ns) 0.08 (ns) 0.04 (ns)
∆ cTW (%) 0.00 (ns) 0.18 (ns) 0.03 (ns) 0.27 (*) 0.52 (*) 0.46 (*) 0.23 (*) 0.56 (*) 0.52 (*) 0.02 (ns) 0.13 (ns) 0.09 (ns)
P
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(a) (b)
Figure 3. Changes in calf intracellular water (cICW) in ml versus changes in calf extracellular fluid (cECW) in ml. (a) contains data 
for all patients whereas (b) includes data for CHF patients only. The dotted line indicates a net zero change in cTW and the dashed 
line represents the linear best fit line. Patients with changes in calf volumes above the dotted line had net increases in cTW and 
patients with changes below the dotted line had net decreases in cTW.
(a) (b)
Figure 4. Percent changes in cTW versus UFV removed as percentage of initial weight. (a) contains data for all patients whereas  
(b) includes data for CHF patients only.
(a) (b)
Figure 5. The initial cECW/cTW ratio versus the initial calf normalized resistivity (CNR). (a) contains data for all patients whereas 
(b) includes data for CHF patients only.
Physiol. Meas. 39 (2018) 125009 (16pp)
10
M Delano and C Sodini 
volume due to posture and changes due to ultrafiltration will be in the same direction and therefore difficult to 
distinguish from one another.
In this study, patients were mostly bedridden, and the majority of the sessions were performed in the morn-
ing after the patients had been asleep all night. The patients remained in a semi-supine position (legs horizontal 
at the same level as their buttocks with torso slightly elevated by a hospital bed and resting on pillows) other than 
briefly when a standing weight was performed. Thus, it is hypothesized that postural shifts would play less of a 
role in these patients when compared with healthy participants or more ambulatory patients. Additionally, some 
patients with high calf fluid overload did not experience much change in cECW even in the semi-supine position. 
This lack of fluid recruitment could indicate that posture is not playing much of a role for these patients; however, 
it could also mean these patients had impaired vascular refilling. Future work should consider the influence of 
posture and/or impaired vascular refilling on changes in calf fluid volumes during hemodialysis.
4.2. Changes in cICW
Changes in ICW during hemodialysis depend on a number of factors including (1) the plasma refill rate, (2) 
the ultrafiltration rate, (3) and dialysate concentrations. (1) The plasma refill rate is higher in patients with 
higher fluid overload (Machek et al 2010). Refill of the intravascular space from the interstitial fluid can cause 
a transient change in the osmotic pressure of the interstitial fluid, resulting in temporary fluid shifts out of 
ICW. (2) Low ultrafiltration rates can cause transient fluid shifts into ICW due to urea gradients that build up 
during hemodialysis (Pastan and Colton 1989, Akcahuseyin et al 2000). Simulations performed by Akcahuseyin 
et al suggest that these fluid shifts into ICW may also be more pronounced in low perfusion areas like the legs 
(Akcahuseyin et al 2000). (3) Dialysate concentrations cause changes in osmotic pressure in ECW that can cause 
lasting changes in ICW (Baigent et al 2001).
(a) (b)
Figure 7. Percent changes in calf extracellular water (cECW) versus the initial calf normalized resistivity (CNR). (a) contains data 
for all patients whereas (b) includes data for CHF patients only.
(a) (b)
Figure 6. Pedal edema score (rated on a scale of 0–3, see section 2.5) compared with calf normalized resistivity (CNR). (a) Contains 
data for all patients whereas (b) includes data for CHF patients only.
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When considering all patients, there was no correlation between changes in cICW and CNR, UFV, UFR, or 
the dialysate serum sodium gradient. However, when eliminating the low CNR patients, there was a significant 
correlation between changes in cICW and UFR. Patients with normalized UFR values lower than 7.6 ml/h/kg 
all had increases in cICW and patients with normalized UFR values higher than 7.6 ml/h/kg all had decreases in 
cICW (see figure 8).
Because UFR was determined based on the target UFV in this study, the two are highly correlated (R2 = 0.95, 
p < 0.001). It is expected that the correlation between changes in cICW and UFV are due to the correlation with 
UFR rather than an independent association. Additionally, the changes in cICW observed are likely transient and 
would not necessarily persist at equilibrium.
4.3. Changes in cTW
Five patients (30%) had increases in cTW over the course of the hemodialysis session. Four of these patients had 
decreases in cECW, but increases in cICW that exceeded the decrease in cECW. One patient had an increase in 
cECW and no change in cICW. Shifts into cICW can occur due to a variety of factors as described in section 4.2 
and these patients did have relatively low UFR that could lead to fluid shifts into cICW. In order for cTW to 
increase, these patients must have had some shift of fluid into cECW from elsewhere in the body to make up 
for the fluid shifts from cECW to cICW. This could occur due to posture or possibly due to relaxation of the 
vasculature, which can occur during hemodialysis (Koomans et al 1984).
4.4. Heterogeneity for patients with low CNR
There was considerable heterogeneity among patients with CNR < 0.1017 Ωm3 kg−1 (N = 7). Of the seven 
patients, there were four different presentations with small N  for each. Because all these patients had high fluid 
overload, the relationship between fluid in the calf and the rest of the body may be different than for the patients 
that were closer to their dry weight. Indeed, the patients closer to dry weight more closely mimic the findings of 
those presented elsewhere (Zhu et al 2008a, 2008b, 2011 and Montgomery et al 2013), whereas the patients with 
low CNR seem to be divergent.
4.5. Comparison of fluid status metrics
CNR correlated with the cECW/cTW ratio at the start of the hemodialysis session and the pedal edema score, 
but not the clinically determined FO. Other researchers have observed a small but statistically significant 
correlation between CNR and a gold standard hydration marker (total extracellular volume as determined by 
bromide dilution divided by the total fat free mass measured by MRI) (Zhu and Levin 2015). The whole body 
fluid overload metric used here was calculated from estimated dry weight and had a number of participants with 
negative fluid overload. This is not possible assuming the definition that the patient dry weight is the point at 
which a patient begin to experience hypotension during hemodialysis (Charra 2007). Additionally, estimated dry 
weight was not available for 3/17 patients. Future research should use a different whole body overload metric, for 
example whole body bioimpedance measurements or dilution measurements, to track the relationship between 
changes in whole body fluid compartments and calf fluid compartments.
(a) (b)
Figure 8. Percent changes in calf intracellular water (cICW) versus the average UFR normalized by patient weight for patients with 
CNR > 0.1017 Ωm3 kg−1. (a) contains data for all patients whereas (b) includes data for CHF patients only.
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4.6. Differences between patients with and without CHF
While patients with CHF did have statistically significant changes in cECW, cTW and weight and patients without 
CHF did not, there were no statistically significant differences between patients with and without CHF in terms 
of demographics or in terms of changes in calf volumes (see tables 1 and 2). Patients with CHF did have fewer 
patients with low CNR compared with patients without CHF (3/9 (33%) in the CHF group versus 4/8 (50%) in 
the non-CHF group). However, they differ by only one patient and this difference could be negligible in a study 
including additional patients.
4.7. Accuracy of calf volume estimations
Estimation of the total calf volume depends on the measured bioimpedance parameters R0 and R∞ and calf 
circumference, along with parameters that are assumed constant over the course of the hemodialysis session 
(ρECW , ρICW  and L). The mean fractional error (
std(Z)
mean(Z)) was 0.28% for R0 and was 0.66% for R∞. The calf 
circumference measurements (with 0.65% at the beginning and 0.87% at the end) therefore dominated cECW 
measurements (see equation (A.7)). Error in cTW and cICW was dominated by errors in R∞ (see equations (A.8) 
and (A.9)). Bioimpedance fractional errors were largest for patients with lower bioimpedance values.
Estimation of cICW and cTW depend on the high frequency resistance R∞. Although data in this study did 
not display the standard capacitive ‘hook’ effect (Scharfetter et al 1998), measurements were still impacted by 
high frequency artifacts from electrode mismatch (Bogónez-Franco et al 2009) and/or cable inductance (Free-
born et al 2018), and hence a cut-off frequency of 200 kHz was used to minimize the impact of these artifacts 
(see figure 9 for an example sweep with the artifacts and fits). Montalibet and McAdams have recently proposed 
a method for reducing the impact of electrode mismatch by performing an additional set of measurements with 
the leads reversed (Montalibet and McAdams 2018). Future work should evaluate this technique and other com-
pensation mechanisms such as short/load calibration to ensure the accuracy of measurements with high fre-
quency data.
Estimations of all calf volumes depend on fluid resistivities ρECW  (all volumes) and ρICW (cICW and cTW) 
only. These values were assumed to be constant over the course of the hemodialysis session and also the same 
for all patients. If ρECW  and ρICW do not change significantly during hemodialysis, examining the percent 
change in calf volumes will cancel out the fluid resistivity terms, allowing ready comparison between patients. 
However, some changes in these fluid resistivities are expected during hemodialysis. If one assumes that the 
plasma sodium concentration equilibrates entirely with the dialysate sodium concentration, there could be vari-
ations in Re of at most 1% for patients with the largest gradients between the initial plasma sodium concentration 
and the dialysate sodium concentration. This would translate into a change in cECW due to changing ρECW  of at 
most 0.67%; any changes larger than 0.67% would be due to other factors (i.e. volume changes). The intracellular 
resistivity ρICW is not expected to change much during hemodialysis as sodium and potassium concentrations 
inside cells are actively regulated.
4.8. Study limitations
This was a small, exploratory study with 17 patients. Future research should enroll additional subjects to further 
evaluate the presented findings. The present study involved measurements at the beginning and end of the 
Figure 9. Example of electrode mismatch ‘hook’ artifact at high frequencies (Bogónez-Franco et al 2009, Montalibet and McAdams 
2018), along with two fits (one with a maximum frequency of 200 kHz (red) and the other with a maximum frequency of 1 MHz 
(yellow)).
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hemodialysis session. Shifts in cICW that are presumed to be transient were observed; future research should 
repeat calf bioimpedance measurements several hours after hemodialysis to observe changes in calf volumes that 
persist at equilibrium. Future research should also investigate how factors that affect vascular refilling, such as 
posture and venous thrombosis, impact the present findings.
4.9. Translation to ambulatory CHF
The findings presented here suggest that changes in calf bioimpedance over the course of hemodialysis depend 
on a combination of the starting calf fluid overload, on the fluid removal rate, and on the total fluid removed. 
Patients with high calf fluid overload (as assessed by calf normalized resistivity less than 0.1017 Ωm3 kg−1) had a 
heterogeneous and less predictable presentation than those with lower levels of calf fluid overload. In an eventual 
ambulatory setting, CHF patients would have the wearable bioimpedance monitor placed when a clinician 
assesses a patient to be at their ‘dry weight’ (i.e. little to no fluid overload). This means that patients should be 
at lower calf fluid overload levels, which had a clearer relationship with changes in calf fluid status compared 
with patients with higher levels of fluid overload. As a patient begins to retain fluid, the wearable monitor could 
alert the patient, caretakers, and/or clinicians accordingly and an appropriate intervention could be made, such 
as additional diuretics, an outpatient visit, or an earlier hospitalization. Providing this feedback loop for CHF 
patients will be a key aspect of managing CHF.
Fluid is removed about an order of magnitude faster during hemodialysis than in an ambulatory setting 
(0 to ∼1 l h−1 in hemodialysis versus 0 to ∼1 l day−1 in ambulatory CHF). This means that any transient fluid 
shifts that were documented during hemodialysis should not exist in an ambulatory CHF case and the body can 
be assumed to be at (ionic) equilibrium.
Another consideration in translation to an ambulatory CHF setting is the expected volume changes in that 
setting. In hemodialysis, a typical patient has up to 4 kg removed 3 days a week. In ambulatory CHF, patients are 
instructed to consult a physician when their weight increases by more than 2 kg over the course of a few days. 
Because these changes are on the same order, the calf bioimpedance system should be able to detect these changes 
so long as the device can consistently measure bioimpedance over a period of several days. However, the system 
would have to account for changes in posture affecting pooling of fluid in the leg.
Because patients in an ambulatory CHF setting will retain fluid relatively slowly, calf bioimpedance is 
expected to change much more slowly compared to the hemodialysis case. In order to maximize observed bio-
impedance changes, we investigated ideal electrode placement for calf bioimpedance measurements in a study 
presented elsewhere (Delano and Sodini 2018). We found that percent changes in calf bioimpedance depend on 
where electrodes are placed on the calf and that the use of ring electrodes is most suitable to determine an average 
change in bioimpedance in the whole calf segment as point electrodes record bioimpedance that is dominated by 
the region near the electrodes.
5. Conclusion
Congestive heart failure (CHF) is a chronic medical condition characterized by fluid overload with high 
readmission rates. Here calf bioimpedance measurements were performed to begin to understand the relationship 
between changes in calf fluid status and the rest of the body. Calf bioimpedance measurements were performed 
before and after hemodialysis and different metrics of fluid status were measured. Changes in calf compartment 
volumes varied with calf fluid overload (as assessed by calf normalized resistivity) and ultrafiltration rate. There 
were larger changes in cECW among patients with lower calf fluid overload as the calf is the last place to dry out 
over the course of hemodialysis. Changes in cICW were highly variable for patients with high calf fluid overload 
than patients with low calf fluid overload. Among patients with low calf fluid overload, flow in and out of cells 
was governed by the ultrafiltration rate. In an ambulatory setting, patients will start ‘dry’ and ideally receive 
treatment before reaching the levels of fluid overload observed in some patients in this study. Translation of calf 
bioimpedance measurements to an ambulatory CHF setting may enable a feedback loop not currently available 
to patients, caretakers, and physicians that would help prevent fluid overload related hospitalizations.
Acknowledgments
The authors would like to thank Dr Maulik Majmudar, Dr Herbert Lin, Haley Dalzell, Bianca Lavelle, Divya 
Padmanabhan, and Rachel Lopdrup (all at Massachusetts General Hospital) for their assistance with clinical 
testing for this study. They would also like to thank Dr Thomas Heldt, Dr Collin Stultz, Jeff Ashe and Tom 
O’Dwyer for their insights, and Will Wang (Swarthmore College) for research assistance. Funding was provided 
by the MIT Medical Electronic Device Realization Center (MEDRC) and the MIT Center for Integrated Circuits 
and Systems (CICS).
Physiol. Meas. 39 (2018) 125009 (16pp)
14
M Delano and C Sodini 
Appendix. Estimating errors in calf volume measurements
Calf volume measurements cECW, cICW, cTW and CNR are measurements that involve multiple measurements 
with their own standard deviations. In order to calculate the standard deviation for cECW, cICW, cTW and 
CNR, the standard deviations for the variables R0, R∞ and the circumference must be combined systematically. 
There are a number of rules that can be used together to calculate the overall standard deviation for a composite 
measurement that consists of multiple measurements with their own standard deviations (assuming the input 
variables are independent and fit a Gaussian distribution) (Taylor 1982). For each rule, Z  is some combination 
of A and B:
Z = A + B : (std(Z))2 = (std(A))2 + (std(B))2 (A.1)
Z = A − B : (std(Z))2 = (std(A))2 + (std(B))2 (A.2)







































Consider, for example, cECW (see equation (9)). Assuming L  and ρECW  are constant and therefore do not 
contribute to the overall standard deviation, there is a circumference term in the numerator, a resistance term in 
































































The factor used for R∞ in equation (A.8) was calculated empirically.
The following equations were used to calculate the absolute or percent difference over the course of the 
hemodialysis session:
std(Abs. Dif f .)2 = std(Final)2 + std(Initial)2 (A.11)










mean(Perc. Diff .)2 (A.12)
where the initial measurement is from before the hemodialysis session and the final measurement is from after 
the hemodialysis session.
To calculate whether two measurements were statistically significantly different, the t-statistic was calculated 
using the mean and standard deviation from both measurements and then the two-tailed p-value was calculated 
using MATLAB’s tcdf function.
The standard deviations for R0 and R∞ were calculated directed from the four measurements performed 
before and after the hemodialysis session. For the circumference measurements, repeat measurements were not 
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available for all patients, so the mean fractional error std(circ)mean(circ)  calculated from patients with repeat measure-
ments was used for all patients. The fractional errors were 0.65% before the session and 0.87% after the session.
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